This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Head and Neck Squamous Cell Carcinoma
and you are
over 18
years old
-
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The purpose is the description of anti-tumor immune responses in general and according to clinical stage and disease free survival (DFS: survival without recurrence (local or distant)) in patients with Head & Neck Squamous Cell Carcinoma Secondary purposes are: - Study of relationship between anti-tumor immune response and qualitative (yes/no) and quantitative (number) presence of circulating tumor cells (CTCs); - Study of relationship between qualitative (yes/no) and quantitative (number) presence of CTCs and clinical stage as well as DFS - Study of relationship between anti-tumor immune response and clinical stage as well as DFS.

Provided treatments

  • Other: Blood sample

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02881918. The sponsor of the trial is Central Hospital, Nancy, France and it is looking for 154 volunteers for the current phase.
Official trial title:
Anti-tumor Specific Immune Response in Head and Neck Cancers